WallStreetZenWallStreetZen

NASDAQ: INZY
Inozyme Pharma Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Inozyme Pharma revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INZY annual revenue was $0.0, with N/A growth year-over-year.

INZY revenue history

Current Revenue
$0.0
Current Earnings
-$102.0M
Current Profit Margin
0%

Be the first to know when INZY announces revenue.

INZY Revenue History By Year

INZY Yearly RevenueINZY RevenueINZY ChangeINZY Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Inozyme Pharma Revenue FAQ

What was INZY's revenue last quarter?

On Invalid Date, Inozyme Pharma (NASDAQ: INZY) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Inozyme Pharma's revenue was $0.00.

What was Inozyme Pharma's revenue in 2024?

Inozyme Pharma's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Inozyme Pharma make in a day?

Based on Inozyme Pharma annual revenue for the past five years, INZY makes an average of $0.00 per day.

What was Inozyme Pharma's annual revenue growth in the past year?

As of Q2 2025, Inozyme Pharma's revenue has grown null year over year. Inozyme Pharma's revenue in the past year totaled $0.00.

How much does Inozyme Pharma make in a year?

Inozyme Pharma's revenue by year for the past five years is:
  • Inozyme Pharma's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Inozyme Pharma's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Inozyme Pharma's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Inozyme Pharma's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Inozyme Pharma's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.